These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8614182)

  • 1. Outpatient anticoagulation issues for the primary care physician.
    Spandorfer JM; Merli GJ
    Med Clin North Am; 1996 Mar; 80(2):475-91. PubMed ID: 8614182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulation in the elderly.
    Henderson MC; White RH
    Curr Opin Pulm Med; 2001 Sep; 7(5):365-70. PubMed ID: 11584191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The quality of anticoagulation management.
    Ansell JE
    Arch Intern Med; 2000 Apr; 160(7):895-6. PubMed ID: 10761952
    [No Abstract]   [Full Text] [Related]  

  • 4. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment patterns and real-world effectiveness of warfarin in nonvalvular atrial fibrillation within a managed care system.
    Darkow T; Vanderplas AM; Lew KH; Kim J; Hauch O
    Curr Med Res Opin; 2005 Oct; 21(10):1583-94. PubMed ID: 16238898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The economics of anticoagulation: what are the issues?
    Am J Manag Care; 2004 Oct; 10(10 Suppl):S292-6. PubMed ID: 15605699
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anticoagulation in cardioversion of atrial fibrillation. Current status and outlook for the future].
    Schimpf T; Stellbrink C
    Med Klin (Munich); 2003 Feb; 98(2):91-5. PubMed ID: 12601533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration.
    Wong YM; Quek YN; Tay JC; Chadachan V; Lee HK
    J Clin Pharm Ther; 2011 Oct; 36(5):585-91. PubMed ID: 21070296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
    Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
    JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Warfarin Anticoagulation and Spontaneous Pectoral Haematomas.
    Yang JC; Makaryus AN
    Heart Lung Circ; 2016 Jul; 25(7):e81-4. PubMed ID: 26948766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updated guidelines on outpatient anticoagulation.
    Wigle P; Hein B; Bloomfield HE; Tubb M; Doherty M
    Am Fam Physician; 2013 Apr; 87(8):556-66. PubMed ID: 23668445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is computer-assisted, long-term warfarin therapy safe and efficacious for patients with nonrheumatic atrial fibrillation?
    Perez-Gomez F
    Nat Clin Pract Cardiovasc Med; 2005 Feb; 2(2):82-3. PubMed ID: 16265377
    [No Abstract]   [Full Text] [Related]  

  • 13. Quality of anticoagulation control in atrial fibrillation.
    Lane DA; Lip GY
    Lancet; 2010 Sep; 376(9745):935-7. PubMed ID: 20801499
    [No Abstract]   [Full Text] [Related]  

  • 14. Anticoagulation for stroke prevention in new atrial fibrillation after coronary artery bypass graft surgery.
    Schulman S; Cybulsky I; Delaney J
    Thromb Res; 2015 May; 135(5):841-5. PubMed ID: 25776468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Old and new anticoagulant drugs: a minireview.
    Mannucci PM; Franchini M
    Ann Med; 2011 Mar; 43(2):116-23. PubMed ID: 21254900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periprocedural anticoagulation management of patients with nonvalvular atrial fibrillation.
    Wysokinski WE; McBane RD; Daniels PR; Litin SC; Hodge DO; Dowling NF; Heit JA
    Mayo Clin Proc; 2008 Jun; 83(6):639-45. PubMed ID: 18533080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of anticoagulant therapy in venous thrombo--embolism.
    O'Sullivan EF
    Med J Aust; 1972 Nov; 2(20):1104-7. PubMed ID: 4640564
    [No Abstract]   [Full Text] [Related]  

  • 18. Periprocedural bridging anticoagulation: current perspectives.
    Palaniswamy C; Selvaraj DR
    Am J Ther; 2011 Jul; 18(4):e89-94. PubMed ID: 20228672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation.
    Douketis JD; Spyropoulos AC; Kaatz S; Becker RC; Caprini JA; Dunn AS; Garcia DA; Jacobson A; Jaffer AK; Kong DF; Schulman S; Turpie AG; Hasselblad V; Ortel TL;
    N Engl J Med; 2015 Aug; 373(9):823-33. PubMed ID: 26095867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The duration of anticoagulation bridging therapy in clinical practice may significantly exceed that observed in clinical trials.
    Deerhake JP; Merz JC; Cooper JV; Eagle KA; Fay WP
    J Thromb Thrombolysis; 2007 Apr; 23(2):107-13. PubMed ID: 17221327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.